A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients with Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients with Radiographic Axial Spondyloarthritis
© 2023 Latin Clinical Trial Center.
All Rights Reserved.
Powered By Millennial Networks
Obrigado por compartilhar. Estou preocupado por não ter ideias criativas. É o seu artigo que me deixa cheio de esperança. Obrigado. Mas, eu tenho uma pergunta, você pode me ajudar?
The point of view of your article has taught me a lot, and I already know how to improve the paper on gate.oi, thank you. https://www.gate.io/signup/XwNAU
The point of view of your article has taught me a lot, and I already know how to improve the paper on gate.oi, thank you. https://www.gate.io/th/signup/XwNAU
I have read your article carefully and I agree with you very much. This has provided a great help for my thesis writing, and I will seriously improve it. However, I don’t know much about a certain place. Can you help me? https://www.gate.io/signup/XwNAU
Thank you for your shening. I am worried that I lack creative ideas. It is your enticle that makes me full of hope. Thank you. But, I have a question, can you help me? https://accounts.binance.com/en/register-person?ref=P9L9FQKY
I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article. https://www.binance.com/kz/register?ref=S5H7X3LP